ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 054

Assessing Completion of Healthcare Transition: A Retrospective Review of Provider Acknowledgment Following Pediatric Rheumatology Transfer

Alonzo Needum1, Kyla Blasingame1, Karissa Chesky1, Jimin Kim1, Charles Lee2, Miriah Gillispie-Taylor3 and Tiphanie Vogel4, 1Baylor College of Medicine, 2Baylor College of Medicine, Houston, TX, 3Baylor College of Medicine/Texas Children's Hospital, Houston, TX, 4Baylor College of Medicine/Texas Children's Hospital

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Thursday, March 19, 2026

Title: Posters: Quality, Health Services, and Education Research I

Session Time: 6:00PM-7:00PM

Background/Purpose: The transition from pediatric to adult rheumatology requires coordinated communication between care teams to ensure patient engagement and continuity of care. Pediatric providers may document transition readiness and final pediatric visits, but there is limited evaluation of whether the pediatric team formally acknowledges successful receipt of care by adult providers after transfer. Acknowledgement of transfer may reduce information loss, clarify provider responsibilities, prevent loss to follow up, and serve as a model for quality improvement within transition workflows. Recognizing the transition completion gap, our team sought to assess how often transitioned patients had documented acknowledgment of the first adult rheumatology visit by their former pediatric provider in the electronic health record (EHR), signaling completion of the transition process.

Methods: We conducted a retrospective chart review of patients who transitioned from pediatric to adult rheumatology care between 2017–2024. The patient list was compiled by the pediatric rheumatology transition team for lead using established tracking logs. We first identified patients who had a documented adult rheumatology visit (Phase 1). We subsequently determined whether their pediatric providers acknowledged the completed transition within the EHR, either through a note or electronic message (Phase 2). Data were managed in Microsoft Excel and analyzed descriptively to evaluate the frequency of documented transition completion.

Results: Of 199 identified patients, 31 (16%) transitioned care internally to an adult rheumatologist embedded in our practice. Of the remaining 168 patients, 143 (85%) completed at least one adult’s rheumatology visit. Among these, 30 (21%) had a corresponding acknowledgment note or electronic message from their pediatric provider confirming receipt of care in the adult setting. Overall, only 30/199 (15%) patients had fully documented transition completion meeting both criteria.

Conclusion: Pediatric provider acknowledgment following healthcare transfer is inconsistently documented. This process gap highlights the need for standardized EHR workflows to alert pediatric teams when former patients establish adult care. Incorporating automated EHR notifications, auditing missed appointments, and creating embedded acknowledgment templates may streamline documentation, reduce provider burden, and potentially prevent gaps in care during the critical transition period. Future directions include correlating acknowledgment completion with patient transition outcomes and identifying modifiable predictors of successful transition continuity.


Disclosures: A. Needum: None; K. Blasingame: None; K. Chesky: None; J. Kim: None; C. Lee: None; M. Gillispie-Taylor: None; T. Vogel: AstraZeneca, 5, Moderna, 2, Novartis, 2, Pediatric provider acknowledgment following healthcare transfer is inconsistently documented. This process gap highlights the need for standardized EH, 12, site PI, Pfizer, 2, Takeda, 6, UCB, 1.

To cite this abstract in AMA style:

Needum A, Blasingame K, Chesky K, Kim J, Lee C, Gillispie-Taylor M, Vogel T. Assessing Completion of Healthcare Transition: A Retrospective Review of Provider Acknowledgment Following Pediatric Rheumatology Transfer [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/assessing-completion-of-healthcare-transition-a-retrospective-review-of-provider-acknowledgment-following-pediatric-rheumatology-transfer/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-completion-of-healthcare-transition-a-retrospective-review-of-provider-acknowledgment-following-pediatric-rheumatology-transfer/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology